semaglutide mlm GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica What Is Semaglutide and Why

GLP-1 medications require specific temperature storage to maintain potency and safety

When someone is using a GLP-1 medication, appetite decreases, digestion slows, and food intake often drops

PlexusDx explains the science behind these combinations and how to approach them safely

Eli Lilly's new pill starts shipping today, Novo Nordisk's oral Wegovy is three months into its launch, and doctors are already telling us that the way patients think about these drugs is shifting fast.

Avexitide has received Breakthrough Therapy Designation by the FDA for post-bariatric hypoglycemia, congenital hyperinsulinism, and more.

Pfizers dose-optimization studies of once-daily formulations of danuglipron ( NCT06567327 and NCT06568731 ) met key pharmacokinetic objectives and confirmed a formulation and dose with the potential to deliver a competitive efficacy and tolerability profile in Phase 3 testing, based on earlier studies of twice-daily danuglipron